DK164088A - Syntetiske peptidantigener til paavisning af hiv-1-infektion - Google Patents

Syntetiske peptidantigener til paavisning af hiv-1-infektion

Info

Publication number
DK164088A
DK164088A DK164088A DK164088A DK164088A DK 164088 A DK164088 A DK 164088A DK 164088 A DK164088 A DK 164088A DK 164088 A DK164088 A DK 164088A DK 164088 A DK164088 A DK 164088A
Authority
DK
Denmark
Prior art keywords
detective
hiv
antigen
infection
peptid
Prior art date
Application number
DK164088A
Other languages
Danish (da)
English (en)
Other versions
DK164088D0 (da
Inventor
Stig Jeansson
Peter Horal
Lars Rymo
Bo Svennerholm
Anders Vahlne
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8701294A external-priority patent/SE468181B/sv
Application filed by Virovahl Sa filed Critical Virovahl Sa
Publication of DK164088D0 publication Critical patent/DK164088D0/da
Publication of DK164088A publication Critical patent/DK164088A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
DK164088A 1987-03-27 1988-03-25 Syntetiske peptidantigener til paavisning af hiv-1-infektion DK164088A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (sv) 1987-03-27 1987-03-27 Hiv-1 gp41 peptid, vaccin och antigen innehaallande peptiden jaemte diagnostiskt test med peptiden
US5172687A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
DK164088D0 DK164088D0 (da) 1988-03-25
DK164088A true DK164088A (da) 1988-09-28

Family

ID=26659756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK164088A DK164088A (da) 1987-03-27 1988-03-25 Syntetiske peptidantigener til paavisning af hiv-1-infektion

Country Status (9)

Country Link
EP (1) EP0284587A3 (fr)
AU (1) AU606928B2 (fr)
CA (1) CA1336473C (fr)
DK (1) DK164088A (fr)
ES (1) ES2013328A6 (fr)
FI (1) FI881418A (fr)
NO (1) NO881151L (fr)
NZ (1) NZ224046A (fr)
RU (1) RU1802871C (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US5204259A (en) * 1988-05-06 1993-04-20 Pharmacia Genetic Engineering, Inc. Methods and systems for producing HIV antigens
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Hiv構成蛋白に対するモノクローナル抗体
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
GB8918200D0 (en) * 1989-08-09 1989-09-20 Medical Res Council The peptide fragments of hiv
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
WO1991008227A1 (fr) * 1989-11-27 1991-06-13 Replico Medical Aktiebolag NOUVEAUX PEPTIDES p17 DU VIH-1, ANTIGENES DE DIAGNOSTIC ET PROCEDE D'IMMUNOANALYSE
EP0510054A1 (fr) * 1990-01-05 1992-10-28 United Biomedical, Inc. Fragments de la proteine du noyau de vih-1
US5427907A (en) * 1990-02-23 1995-06-27 Virginia Commonwealth University Assay for equine infectious anemia virus
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
ES2293643T5 (es) 1994-10-20 2012-02-02 Institut Pasteur Secuencias nucleotídicas de antígenos retrovíricos vih-1 del grupo (o subgrupo) o.
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
CA2350911A1 (fr) 1998-11-16 2000-05-25 Board Of Regents, The University Of Texas System Induction de lymphocytes t specifiques du vih
DE60233235D1 (de) 2001-09-04 2009-09-17 Wisconsin Alumni Res Found Flüssigkristallumschaltmechanismus
US7807348B2 (en) 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
AU2002368337A1 (en) 2002-11-08 2004-06-03 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
WO2005010160A2 (fr) 2003-07-17 2005-02-03 Wisconsin Alumni Research Foundation Cristaux liquides a toxicite reduite et applications associees

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588254T2 (de) * 1984-10-18 2008-06-26 Institut Pasteur GAG-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
WO1986006414A1 (fr) * 1985-04-29 1986-11-06 Genetic Systems Corporation Antigenes synthetiques permettant la detection d'une infection apparentee au sida
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharmaceutical Corp., Raritan Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
WO1987007616A1 (fr) * 1986-06-12 1987-12-17 Biogen N.V. Peptides impliques dans la pathogenese d'une infection du type hiv

Also Published As

Publication number Publication date
NO881151D0 (no) 1988-03-16
EP0284587A2 (fr) 1988-09-28
AU606928B2 (en) 1991-02-21
DK164088D0 (da) 1988-03-25
RU1802871C (ru) 1993-03-15
AU1380788A (en) 1988-09-29
FI881418A (fi) 1988-09-28
CA1336473C (fr) 1995-07-25
NZ224046A (en) 1990-07-26
NO881151L (no) 1988-09-28
FI881418A0 (fi) 1988-03-24
EP0284587A3 (fr) 1990-11-22
ES2013328A6 (es) 1990-05-01

Similar Documents

Publication Publication Date Title
DK164088A (da) Syntetiske peptidantigener til paavisning af hiv-1-infektion
DK198086D0 (da) Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier
DK398887D0 (da) Antistoffer
DK213987D0 (da) Immunogen
ATA184790A (de) Schlusssteinset
DK229587A (da) Fremgangsmaade til paavisning af infektion
DK174388A (da) Cycliske peptider
DK549688D0 (da) Fremstilling af peptider
DK290588A (da) Renin-inhiberebde peptid
DK531986D0 (da) Peptider
DK185988D0 (da) Anvendelse af antigen
DK253087D0 (da) Syntetiske natriuretiske peptider
DK57489A (da) Benzoxazinderivater
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DE3482813D1 (de) Adult t-zell-leukemiavirus-antigenpeptid.
DK34888A (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK375488D0 (da) Vaccine
DK554986D0 (da) Antistof
ZA882095B (en) Synthetic peptide antigens for the detection of hiv-1 infection
NO903760D0 (no) Syntetiske peptid antigener for detektering av htlv-1 infeksjon.
DK554886A (da) Antistoffer
DK142788A (da) Fremgangsmaade til fremstilling af chlorerede olefiner
KR880007435U (ko) 봉숭아물 착색기
DK460987D0 (da) Fremstilling af proteiner.
DK434986D0 (da) Peptider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment